Quantbot Technologies LP Avrobio, Inc. Transaction History

Quantbot Technologies LP

  • $2.36 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022
BUY
$0.75 - $1.33 $28 - $50
38 Added 0.72%
5,338 $4,000
Q1 2022

May 16, 2022
BUY
$1.29 - $4.04 $645 - $2,020
500 Added 10.42%
5,300 $6,000
Q4 2021

Feb 11, 2022
SELL
$3.45 - $6.05 $11,730 - $20,570
-3,400 Reduced 41.46%
4,800 $18,000
Q3 2021

Nov 09, 2021
BUY
$5.53 - $9.28 $45,346 - $76,096
8,200 New
8,200 $45,000

Others Institutions Holding AVRO

# of Institutions
1
Shares Held
559K
Call Options Held
0
Put Options Held
0
View Full List

About AVROBIO, Inc.

AVRO Quotes by TradingView
  • Ticker AVRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,773,900
  • Description
  • AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...
More about AVRO
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email